Articles On Medical Developments International (ASX:MVP)

The S&P/ASX 200 index has followed the lead of U.S. markets and is pushing higher on Monday. In afternoon trade the benchmark index is up 0.4% to 6,733.8 points. Four shares that are climbing more than most today are listed below. Here...

Australia’s S&P/ASX 200 (Index: ^AXJO)(ASX: XJO) and ALL ORDINARIES (Index: ^AXAO) (ASX: XAO) indices finished higher on Friday. Here’s a short recap of the Australian market: S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) higher 0.36% to...

The Medical Developments International Ltd (ASX: MVP) share price is pushing higher on Friday. In late morning trade the healthcare company’s shares are up 1% to $7.16. Why is the Medical Developments International share price pushing high...

New Zealand’s medicines regulator has recommended the country fall in line with Australia’s new codeine restrictions, and pharmaceutical companies are backing the decision. Yesterday, Medsafe recommended that all medications containing code...

It has been a very disappointing day of trade for the S&P/ASX 200 index on Tuesday. In afternoon trade the benchmark index is down a sizeable 1.95% to 6,728.6 points. Four shares that have defied the market sell off today are listed be...

On 2 December 2019, the S&P/ASX 200 Health Care Sector (XHJ) traded higher at 42,106.3 points, with a rise of 0.83% compared to the last close. The S&P/ASX 200 Index traded at 6,862.3 points, up by 0.24% from its previous close. YT...

The uncertainties in almost every aspect of human life are uninvited guests for which not everyone is prepared. Similarly, many investors put their hard-earned money into risk carrying investment vehicles without having the knowledge of the...

Medical Developments International (ASX:MVP) has announced that the Chinese National Medical Product Administration (NMPA) has approved the opening of its Investigative New Drug (IND) application for Penthrox.

Although it gave back some of its morning gains, the S&P/ASX 200 index was on form again on Monday. The benchmark index finished the day 0.3% higher at 6,731.4 points. This led to a good number of shares charging higher, with some even...

Australia’s S&P/ASX 200 (Index: ^AXJO)(ASX: XJO) and ALL ORDINARIES (Index: ^AXAO) (ASX: XAO) indices finished lower on Thursday. Here’s a short recap of the Australian market: S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) lower 0.79% to...

In afternoon trade the S&P/ASX 200 index is having another day to forget. At the time of writing the benchmark index is down a sizeable 1% to 6,655.9 points. Four shares that have not let that hold them back today are listed below. Her...

The Titomic Ltd (ASX: TTT) share price has been amongst the best performers on the market on Thursday. In morning trade the digital manufacturing solutions company’s shares are up 14% to $1.28. Why is the Titomic share price rocketing high...

The Medical Developments International (ASX: MVP) share price is up 8% after making an announcement to investors. Medical Developments International is a healthcare company focused on emergency pain relief and respiratory products. The comp...

The Medical Developments International Ltd (ASX: MVP) share price has been a strong performer on Thursday morning. At the time of writing the healthcare company’s shares are up 5% to $6.33. Why is the Medical Developments International sha...

The Paradigm Biopharmaceuticals Ltd (ASX: PAR) share price was on form again on Thursday. The biopharmaceutical company’s shares pushed 4% higher to $2.93 on the day of its annual general meeting. This latest gain means the Paradigm share...

The Medical Developments International Ltd  (ASX: MVP) share price was one of the big gainers on the ASX last month. The Aussie medical devices group had a huge month amid announcing a new CSIRO deal and several strong Penthrox updates. Wh...

The Medical Developments International Ltd (ASX: MVP) share price will be on watch on Tuesday following the release of a positive announcement. What did Medical Developments International announce? This morning Medical Developments Interna...

Australia has an excellent medical research, and health care infrastructure, as a result the Australian health care system has been the global benchmark for decades. In Australia, the health care industry is backed by the national and state...

Melbourne-based Medical Developments International (ASX:MVP) has announced that Penthrox, its fast-onset, non-opioid analgesic for pain relief by self-administration, has been launched in Italy.

23 Oct 2019 - Medical Developments International (ASX:MVP) is delighted to announce that Penthrox has been launched in Italy.

Botanix Pharmaceuticals’ (ASX:BOT) shares have halved after its anti-acne drug failed its clinical trial. If you read most of the company’s announcement and you’d would have thought the 368 patient trial was a success. Its drug, BTX 1303, w...

It has been a positive day of trade for the S&P/ASX 200 index on Tuesday. At the time of writing the benchmark index is up 0.25% to 6,670.4 points. Four shares that are climbing more than most today are listed below. Here’s why they ar...

The Cochlear Limited (ASX: COH) share price has dropped lower on Tuesday following the release of its AGM update. In morning trade the hearing solutions company’s shares are down 3% to $207.89. What was in Cochlear’s update? Much of today’...

In morning trade the Megaport Ltd (ASX: MP1) share price has sunk lower despite the release of a solid first quarter update. At the time of writing the shares of the leading provider of elastic interconnection services are down 8% to $9.43...

The Medical Developments International Ltd (ASX: MVP) share price will be on watch this morning follow a positive announcement relating to its Penthrox product. What is Penthrox? Penthrox, or the green whistle, is a fast onset, non-opioid...

ResMed Inc (ASX: RMD) has grown exponentially over the last few years, and is now a large-cap company and one of the leading healthcare blue-chips trading on the ASX, alongside the likes of CSL Limited (ASX: CSL) and Cochlear Limited (AS...

You may have heard about an opioid crisis over in the US; it was declared a public health emergency in 2017 amid 130 deaths every day from opioid-related drug overdoses and 2.1 million people with an opioid use disorder. In Australia, the p...

The notion of ‘everything old is new again’ applies not just to fickle fashion trends, but to drug development as well. Drug reformulations are all the rage and it’s not such a bad thing. Think of Paradigm Biopharmaceuticals (ASX:PAR) with...

The Medical Developments International Ltd (ASX: MVP) share price is on the rise today after the company reported its results for the 2019 financial year (FY19) this morning. MVP shares opened at $4.76, but have since jumped to $4.94 at th...

The Australian health system is tagged amongst the best in the world and focusses on providing safe and affordable health care for all the Australians. The federal, state and local government jointly run the system to ensure its adherence....

Healthcare being a large industry in Australia is a significant contributor to the country’s economy. The below-mentioned ASX listed healthcare stocks have been performing well over the past few months, plus have made strong operational pro...

The S&P/ASX 200 index has charged higher on Friday thanks largely to strong gains in the banking sector. In afternoon trade the benchmark index is up 0.7% to 6,697.5 points. Four shares that have climbed more than most today are listed...

The Medical Developments Ltd (ASX: MVP) share price is up 7% or 41 cents to $6.20 today after the company behind the Penthrox pain-killing medical device provided investors an update on its Holy Grail-like quest to get approval for the dev...

The AVITA Medical Ltd (ASX: AVH) share price was one of the best performers on the local market during the last financial year. During the period the regenerative medicine company’s shares rose an incredible 500%. The good news for shareho...